Annual report pursuant to Section 13 and 15(d)

Inventories, net (Tables)

v3.22.2.2
Inventories, net (Tables)
12 Months Ended
May 31, 2022
Inventory Disclosure [Abstract]  
Summary of Inventories, net of reserves

​

​

​

​

​

​

​

​

​

​

As of May 31,

(in thousands)

    

2022

    

2021

Raw materials

​

$

16,264

​

$

28,085

Work-in-progress

​

 

1,665

​

 

65,394

Total inventories, net

​

$

17,929

​

$

93,479

Schedule of remaining shelf life of inventory

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Raw Materials

​

​

Work-in-progress

​

​

​

(in thousands, Expiration period ending May 31, )

    

Remaining shelf-life (mos)

    

Specialized

​

Resins

​

Other

​

Total Raw Materials

​

Bulk drug product

​

Finished drug product

​

Total inventories

2023

​

0 to 12

$

3,658

​

-

​

1,421

$

5,079

​

$

1,824

​

$

-

​

$

6,903

2024

​

13 to 24

​

682

​

16,264

​

1,590

​

18,536

​

​

1,665

​

​

-

​

​

20,201

2025

​

25 to 36

​

2,099

​

-

​

-

​

2,099

​

​

-

​

​

29,142

​

​

31,241

2026

​

37 to 48

​

731

​

-

​

-

​

731

​

​

-

​

​

32,344

​

​

33,075

Thereafter

​

49 or more

​

-

​

-

​

-

​

-

​

​

-

​

​

-

​

​

-

Inventories, gross

​

​

​

7,170

​

16,264

​

3,011

​

26,445

​

​

3,489

​

​

61,486

​

​

91,420

Write-off

​

​

​

(7,170)

​

-

​

(3,011)

​

(10,181)

​

​

(1,824)

​

​

(61,486)

​

​

(73,491)

Inventories, net

​

​

$

-

​

16,264

​

-

$

16,264

​

$

1,665

​

$

-

​

$

17,929